CBDMD INC (YCBD) Stock Price, Quote, News and Overview
NYSEARCA:YCBD - NYSE Arca - US12482W3097 - Common Stock - Currency: USD
YCBD Quote, Performance and Key Statistics
0.43
-0.02 (-4.44%)
The current stock price of YCBD is 0.43 USD. In the past month the price decreased by -27.12%. In the past year, price decreased by -41.1%.
YCBD Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 67.8 | 836.73B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 28.22 | 402.13B | ||
| JNJ | JOHNSON & JOHNSON | 16.39 | 394.22B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 20.69 | 231.63B | ||
| MRK | MERCK & CO. INC. | 11.95 | 230.88B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.76 | 215.72B | ||
| PFE | PFIZER INC | 8.57 | 151.03B | ||
| SNY | SANOFI-ADR | 13.4 | 134.76B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 50.77 | 117.39B | ||
| GSK | GSK PLC-SPON ADR | 7.87 | 75.67B | ||
| ZTS | ZOETIS INC | 27.92 | 74.58B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 32 | 44.64B |
Related stock screener links
About YCBD
Company Profile
cbdMD, Inc. engages in the business of operating cannabidiol brands such as Paw cannabidiol and cbdMD botanicals. The company is headquartered in Charlotte, North Carolina and currently employs 52 full-time employees. The company went IPO on 2017-11-17. The firm owns and operates CBD brands cbdMD, Paw CBD and cbdMD Botanicals. Its cbdMD brand of products includes a range of premium every day and functional CBD products, including tinctures; gummies; topicals; capsules; drink mixes; and sleep, focus and calming aids.Its Paw CBD brand of products includes a line of veterinarian-formulated products including tinctures, chews, topicals products in varying strengths and formulas. Its cbdMD Botanicals brand of beauty and skincare products features facial oil and serum, toners, moisturizers, clear skin, facial masks, exfoliants and body care stock-keeping units (SKU). cbdMD, Paw CBD and cbdMD Botanicals products are distributed through its e-commerce websites, third party ecommerce sites, select distributors and marketing partners as well as a variety of brick-and-mortar retailers. Its products are sold through www.cbdmd.com, www.pawcbd.com, and cbdmdbotanicals.com Websites.
Company Info
CBDMD INC
8845 Red Oak Blvd
Charlotte NORTH CAROLINA 28217 US
CEO: Martin A. Sumichrast
Employees: 52
Company Website: https://www.cbdmd.com/
Investor Relations: http://www.cbdmd.com/investors
Phone: 17044453060
CBDMD INC / YCBD FAQ
What is the stock price of CBDMD INC today?
The current stock price of YCBD is 0.43 USD. The price decreased by -4.44% in the last trading session.
What is the ticker symbol for CBDMD INC stock?
The exchange symbol of CBDMD INC is YCBD and it is listed on the NYSE Arca exchange.
On which exchange is YCBD stock listed?
YCBD stock is listed on the NYSE Arca exchange.
What is the price forecast or stock price prediction for CBDMD INC stock?
7 analysts have analysed YCBD and the average price target is 2.04 USD. This implies a price increase of 374.42% is expected in the next year compared to the current price of 0.43. Check the CBDMD INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is CBDMD INC worth?
CBDMD INC (YCBD) has a market capitalization of 2.69M USD. This makes YCBD a Nano Cap stock.
How many employees does CBDMD INC have?
CBDMD INC (YCBD) currently has 52 employees.
What are the support and resistance levels for CBDMD INC (YCBD) stock?
CBDMD INC (YCBD) has a support level at 0.42 and a resistance level at 0.54. Check the full technical report for a detailed analysis of YCBD support and resistance levels.
Is CBDMD INC (YCBD) expected to grow?
The Revenue of CBDMD INC (YCBD) is expected to grow by 9.38% in the next year. Check the estimates tab for more information on the YCBD EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy CBDMD INC (YCBD) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of YCBD, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of YCBD, evaluating the profitability, health, valuation and growth aspects
- CBDMD INC (YCBD) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- CBDMD INC (YCBD) Sales and EPS estimates to see what analysts future expectations are.
- CBDMD INC (YCBD) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- CBDMD INC (YCBD) Insider and Institutional Ownership to learn about the owners and their transactions.
- CBDMD INC (YCBD) Stock Chart to make your own analysis
- CBDMD INC (YCBD) Latest news and press-releases to stay up to date.
Does CBDMD INC (YCBD) stock pay dividends?
YCBD does not pay a dividend.
When does CBDMD INC (YCBD) report earnings?
CBDMD INC (YCBD) will report earnings on 2025-05-13.
What is the Price/Earnings (PE) ratio of CBDMD INC (YCBD)?
CBDMD INC (YCBD) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.28).
What is the Short Interest ratio of CBDMD INC (YCBD) stock?
The outstanding short interest for CBDMD INC (YCBD) is 10.36% of its float. Check the ownership tab for more information on the YCBD short interest.
YCBD Technical Analysis
YCBD Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to YCBD. YCBD has a bad profitability rating. Also its financial health evaluation is rather negative.
YCBD Financial Highlights
Over the last trailing twelve months YCBD reported a non-GAAP Earnings per Share(EPS) of -1.28. The EPS increased by 86.59% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -72.81% | ||
| ROE | -392.38% | ||
| Debt/Equity | 0 |
YCBD Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to YCBD. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 71.11% and a revenue growth 9.38% for YCBD